Series date: 
09/04/2025 - 12:00pm CDT to 06/25/2026 - 1:00pm CDT
Location

Please check the individual session for location or broadcast availability.  


Frequency

Weekly


Series Director

Grace Tamesis, MD, MPH

Series Co-Director

Lenora Noroski, MD, MPH


Target Audience
This activity is designed for specialty and subspecialty clinicians across all disciplines, with emphasis in immunology, allergy and retrovirology, and is open to all those interested as faculty, clinicians, scientists, educators, public health and social service professionals, fellows, residents, medical students, and all those with whom the topics resonate within the professional medical-healthcare realms.
Needs Statement

The Immunology, Allergy, and Retrovirology Grand Rounds aims to address the needs of all participants — as learners and audience members and as teachers, speakers, and expert panelists — through a dynamic educational process that captures the evolving scope of these fields. The forum will explore published research results, new clinical evidence, expert recommendations, practical demonstrations of clinical competencies, and strategies for quality improvement. There is an overarching need for instruction in allergic-immune disorders and affected populations that bridges basic science and practical clinical applications from bench to bedside to the larger community for all who care for patients and their families. Embracing the spirit of graduate medical education, this forum will provide faculty development in educational methods, humanism, professionalism, and mentorship while supporting self-assessment, growth, and the enjoyment of life-long learning and teaching. Ultimately, the series aims to empower participants as learners-teachers; to integrate up-to-date, evidence-based recommendations into patient care; and to adapt their clinical practice in alignment with current best practices and standards while upholding professional development.


Educational Methods

Educational methods will include lectures, case presentations, literature review, panel discussion, and audience response.  


Objectives

At the conclusion of the sessions, the participants should be able to:

  • Discuss and explain the modes of action of new therapies and drugs, new interventions, and current standards of testing in immunology, allergy, and retrovirology.
  • Identify appropriate clinical and laboratory findings that are relevant and abnormal for patients with allergic, immunologic, and retroviral conditions.
  • Integrate up-to-date practice recommendations and guidelines into patient care, with an emphasis on individualized and evidence-based approaches.
  • Evaluate and address variations in patient care approaches by engaging in interdisciplinary discussion and applying strategies to standardize best practices across diverse clinical backgrounds and learner expertise.

Evaluation

Participants may be asked to complete a session evaluation.


Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Series Coordinator 
Magda Gomez
[email protected]
832-824-1303
Series location: 
Texas Children's Hospital
6621 Main Street
Houston, TX 77030
United States